Remdesivir Safe Despite Advanced CKD, Study Finds
Remdesivir is not currently recommended for use in patients with an estimated glomerular filtration rate (eGFR) less than 30 mL/min/1.73 m2.
Adverse Effects
Acute Kidney Injury After CAR-T Therapy for Non-Hodgkin Lymphoma
Researchers sought to determine the incidence and possible risk factors of acute kidney injury in patients undergoing a chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma.
Potassium Binders for Hyperkalemia in CKD Compared, Characterized
Each of the 4 potassium binders that were compared in a study had advantages and disadvantages, investigators reported.
eGFR Dip With Dapagliflozin Not Linked to Higher CKD Progression Risk
Understanding clinical characteristics associated with a decline in eGFR can help guide optimal use of SGLT2 inhibitors in clinical practice, according to investigators.
Azithromycin Ups Sudden Cardiac Death Risk in the Hemodialysis Population
According to investigators, clinicians need to weigh the antimicrobial benefits of azithromycin, levofloxacin, and amoxicillin-based antibiotics against their potential cardiac risks in the hemodialysis population.
Inappropriate Antibiotic Prescribing for Uncomplicated Cystitis Still Occurs
Urologists appear more likely than other specialists to inappropriately treat uncomplicated cystitis, according to study findings.
Fractures After Kidney Transplantation Tied With Poor Survival
Clinicians need to individualize immunosuppressive regimens to balance the efficacy of immunosuppression to prevent graft rejection against the need to reduce fracture and infection risks after kidney transplantation, according to investigators.
Higher Fluoroquinolone Doses May Be Toxic in Advanced CKD
Guidelines recommend that clinicians prescribe fluoroquinolone at lower doses in patients with reduced kidney function.
Stopping RAS Inhibitors After AKI Ups Risk for Adverse Events
Findings may aid physicians in their clinical decision-making in the absence of randomized clinical trial data, according to investigators.
Rosuvastatin Increases Risk of Hematuria, Proteinuria
Few real-world studies have investigated the risks of hematuria and proteinuria associated with rosuvastatin use.
- Loading...
Loading...
Next post in Chronic Kidney Disease (CKD)
Loading... 
Loading...